---
title: "Shanghai RAAS: The net profit for the third quarter was 441 million yuan, a decrease of 26.16%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/262869679.md"
description: "Shanghai RAAS announced that its revenue for the third quarter was 2.139 billion yuan, an increase of 3.72% year-on-year; net profit was 441 million yuan, a decrease of 26.16%. Revenue for the first three quarters was 6.091 billion yuan, a year-on-year decrease of 3.54%; net profit was 1.471 billion yuan, a year-on-year decrease of 19.97%"
datetime: "2025-10-27T10:28:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262869679.md)
  - [en](https://longbridge.com/en/news/262869679.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262869679.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/262869679.md) | [繁體中文](https://longbridge.com/zh-HK/news/262869679.md)


# Shanghai RAAS: The net profit for the third quarter was 441 million yuan, a decrease of 26.16%

Shanghai RAAS announced that its revenue for the third quarter was 2.139 billion yuan, an increase of 3.72% year-on-year; net profit was 441 million yuan, a decrease of 26.16%. Revenue for the first three quarters was 6.091 billion yuan, a year-on-year decrease of 3.54%; net profit was 1.471 billion yuan, a year-on-year decrease of 19.97%

### Related Stocks

- [Shanghai RAAS (002252.CN)](https://longbridge.com/en/quote/002252.CN.md)

## Related News & Research

- [RAAS Blood Products Gets Plasma Collection License for Fengzhen Tonglu Plasma Collection Station](https://longbridge.com/en/news/278489427.md)
- [Shanghai RAAS Blood Products Gets Trial Approval for Blood Clotting Disorder](https://longbridge.com/en/news/264390728.md)
- [Volkswagen reclaims top spot in China car sales, BYD falls to fourth as EV subsidies fade](https://longbridge.com/en/news/279028881.md)
- [China January-February unwrought copper imports down 16.1% at 700,000 metric tons - customs](https://longbridge.com/en/news/278485910.md)
- [China Medical System says China approves Desidustat tablets for CKD anaemia](https://longbridge.com/en/news/279028848.md)